Gilead Sciences (GILD) AGM 2025 summary

Opening remarks and agenda

• Meeting called to order by the Chairman and CEO, with introductions of the Board, executive team, and independent auditor present.

• Formal business conducted per agenda and proxy statement, with opportunities for stockholder questions on business items and company matters.

• Quorum established with proxies for 89.9% of outstanding shares.

Shareholder proposals

• Six shareholder proposals presented: CEO pay ratio in compensation, independent board chair policy, comprehensive human rights policy, and a report on DEI practices for contractors, among others.

• Proponents of each proposal provided statements, with Board opposition included in the proxy statement.

Overview of voting outcomes

• All nine director nominees elected with at least 93.4% approval.

• Ratification of Ernst & Young as auditor passed with 92.9% approval.

• Advisory vote on executive compensation approved with 91% in favor.

• Shareholder proposals: CEO pay ratio (8% in favor), independent board chair (36.2%), human rights policy (35.9%), DEI risk report (1%)—none approved.